We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Oxford International are pleased to announce the Pharmaceutical Technology Summit being held on 6th-8th June 2006 at Le Montreux Palace, Montreux, Switzerland.
Inpharmatica Ltd has announced a collaboration agreement with Ingenuity Systems, Inc, Redwood City, California. Under the terms of the agreement, the two companies will work together to bring their customers the benefits of using in tandem two advanced and independently-developed drug discovery tools.
The rate of patients who adhere to antiretroviral (ARV) therapy is higher in Uganda than in any other country in the world, according to Peter Reis, vice president of the U.S.-based AIDS Healthcare Foundation (AHF).
Patients aged 70 and older who continued to take the antidepressant that initially helped them to recover from their first depressive episode were 60 percent less likely to experience a new depressive episode than those who stopped taking the medication, according to a study published in the New England Journal of Medicine.
The International Association of Pharmaceuticals Companies (MAFS) claims that the Czech government has still not amended its "nontransparent" medicines categorization policy, which the group first lobbied to change in March 2005.
IMS Health, a private analysis firm, has reported that prescription medicine spending in Australia has fallen below the country's rate of inflation a statistic that has led many to question the government's recent drug-pricing maneuvers.
Entelos, a company specializing in predictive biosimulation technologies for drug discovery, development, and commercialization, has expanded its research collaboration with Johnson & Johnson Pharmaceutical R&D, to include multiple therapeutic areas over a five-year term.
Cato Research Ltd., a global contract research organization (CRO) providing a full-range of drug development services and regulatory expertise for clients in the pharmaceutical, biotechnology, and medical device industries, and JSW-Research Forschungslabor GmbH, an Austrian CRO specializing in research and development of novel therapeutics for central nervous system (CNS) disorders, announced today a strategic business development collaboration focused on expansion of the companies' operations throughout the European Union and Eastern Europe.
Global bio-nanotech company pSivida Limitedtoday announced
that following anindependent audit of its Boston, Massachusetts facility by a EuropeanQualified Person (QP), the QP issued a certificate that Medidur ismanufactured to a standard of GMP (Good Manufacturing Practice)equivalent to that in the European Union, as set out in directive2003/94/EC and the EC Guide to Good Manufacturing Practice.